UAE IVF DRUGS AND FOOD SUPPLEMENTS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

UAE IVF Drugs and Food Supplements Market Analysis & Forecast 2026-2033

The UAE IVF drugs and food supplements market is estimated to be valued at USD 26.4 Mn in 2026 and expected to reach USD 41.3 Mn by 2033, witnessing a CAGR of 6.6% over the forecast period (2026-2033).

Key Takeaways

• Based on Product Type, the drugs segment is expected to lead the market with 60% of the share in 2026.
• Based on Distribution Channel, the hospital pharmacies segment is expected to hold 52.7% share of the market in 2026.

Market Overview

IVF is a type of assisted reproduction technology in which a woman's reproductive system is artificially encouraged to create oocytes, which are then harvested, fertilized in a lab, and placed in the uterus. Due to complications, IVF specialist provides drugs and food supplements to patients undergoing IVF treatment.

IVF treatment procedure includes ovarian stimulation, ovulation induction, oocyte harvest, sperm fertilization, and transport of the fertilized oocytes for implantation. There are various drugs which are commonly used for IVF treatment such as Clomiphene used for inducing ovulation and also injectables available for IVF treatment which includes gonadotropin-releasing hormone (GnRH) and follicle-stimulating hormone (FSH), that produce progesterone to maintain the pregnancy.

GonGnRH antagonist inhibit of a premature LH rise and also there are various food supplements which are commonly provided to the patients under IVF treatment such as Coenzyme Q10 (CoQ10) to improve egg quality, sperm quality, and pregnancy rates and DHEA used as an adjuvant for in vitro fertilization (IVF) cycles in poor ovarian responders.

Current Events and their Impacts on the UAE IVF Drugs and Food Supplements Market

How Much Does IVF Treatment Really Cost in the UAE?

Segmental Insights 

UAE IVF Drugs and Food Supplements Insights, By Product Type: Drugs Dominates with Injectable Hormones Driving IVF Success Across UAE Fertility Treatments

In terms of product type, the drugs segment is expected to lead the market with 60% of the share in 2026. Injectable hormones, such as hCG, FSH, hMG, and GnRH analogs, will be the most popular because they are necessary for starting ovulation, stimulating follicles, and controlling the cycle. Clomiphene citrate is still a common prescription, but GnRH agonists and antagonists give high precise hormonal control in advanced IVF protocols. 

For example, in February 2026, Fakih IVF opens a new branch in Khalifa City, Abu Dhabi, which makes the region's fertility healthcare system better. The expansion makes it easier for patients to get advanced reproductive treatments, encourages medical tourism, and indirectly increases the demand for IVF drugs and food supplements. This strengthens Abu Dhabi's position as a major center for reproductive medicine in the UAE.

UAE IVF Drugs and Food Supplements Insights, By Distribution Channel: Hospital Pharmacies Lead, Ensuring Regulated Access Through Specialized Fertility Centers

In terms of distribution channel, the hospital pharmacies segment is expected to hold 52.7% share of the market in 2026, because patients rely on specialized fertility centers to get their prescribed IVF drugs directly. Centralized dispensing makes sure that treatments are correct, follow the rules, and are overseen by doctors. This makes them even more dominant than retail and online channels in the UAE reproductive healthcare market.

Market Report Scope 

UAE IVF Drugs and Food Supplements Market Driver

Rising Infertility Rates

Infertility in the UAE is becoming increasingly interconnected to lifestyle factors like stress, obesity, and delayed childbearing. These problems are driving couples seek out more advanced reproductive solutions, especially IVF. As a result of this, the UAE IVF Drugs and Food Supplements Market growth accelerates, with more people wanting medicines like Clomiphene, hCG, FSH, hMG, and GnRH agonists/antagonists. Along with these drugs, people are also taking nutritional supplements to improve their chances of getting pregnant, expanding the market.

Growing Awareness & Acceptance of IVF

Public campaigns and private fertility clinics in the UAE are working hard to make IVF treatments more common, which will help break down the stigma around them and encourage couples to explore assisted reproductive technologies. As a result of this change in culture, people are more willing to use hormone therapies and nutritional supplements together to improve their chances of success. Consequently, the UAE IVF drugs and food supplements market demand is growing as more couples choose holistic methods of fertility care. More people are becoming aware of advanced reproductive healthcare solutions, which is not only increasing adoption but also building trust in them.

UAE IVF Drugs and Food Supplements Market Opportunity

Expansion of Medical Tourism

Dubai and Abu Dhabi are trying to become global fertility centers that draw patients from the GCC, Africa, and Europe. The UAE is a popular place for IVF treatments because it has advanced healthcare infrastructure, skilled specialists, and low prices. Clinics and drug companies can take advantage of this by offering affordable IVF packages that come with food supplements. This will improve treatment outcomes and make patients happier. The UAE IVF Drugs and Food Supplements market forecast show that this trend is a significant opportunity, which will drive international demand and long-term growth.

For instance, in June 2025, the $450 million purchase of ART Fertility Clinics by KKR-backed IVI highlights that Abu Dhabi and Dubai are becoming more important in reproductive health care. The news is mostly about companies growing, but it also has something to do with IVF drugs and food supplements. A greater number of patients will mean more demand for hormone therapies and nutritional support. 

Analyst Opinion (Expert Opinion)

• The UAE IVF drugs and food supplements market is growing quickly because rising infertility rates, health problems related to lifestyle, and increasing awareness of assisted reproductive technologies. According to data from regional health authorities, the rate of infertility in the Middle East is between 10% and 15%. This has led to a rise in demand for advanced fertility treatments and nutritional supplements that help with fertility.
• Higher adoption rates are due to government efforts to improve healthcare infrastructure and the growth of specialized fertility clinics. Reports from the industry show that the UAE has more than 20 dedicated fertility centers. patient inflows not only from domestic demand but also from medical tourism, particularly from neighboring GCC countries. This patient base from other countries is making the UAE an even better place for reproductive health care solutions in the region.

Recent Developments

• In February 2026, Umniya Fertility's launch in Abu Dhabi is making the UAE's reproductive healthcare system ecosystem with a holistic, results-based approach. The news focuses on expanding services and putting patients first, but it also has to do with IVF drugs and food supplements. This is because more fertility treatments mean more hormone therapies and nutritional support across the region.
• In January 2026, the launch of a new hormone therapy by Mubadala Bio in Abu Dhabi shows that the UAE is dedicated about improving women's health. This expansion strengthens reproductive healthcare services by directly linking hormone-based treatments to IVF drugs and indirectly affecting the demand for supportive supplements. This makes Abu Dhabi a leader in regional fertility innovation and patient care.

Market Segmentation

• By Product Type
  • Drugs
    • Clomiphene
    • Injectable Hormones (Human chorionic gonadotropin (hCG)
    • Follicle-stimulating hormone (FSH)
    • Human menopausal gonadotropin (hMG)
    • Gonadotropin-releasing hormone (GnRH)
    • GnRH agonist
    • GonGnRH antagonist
  • Food Supplements
• By Distribution Channel
  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
•   Key Players
  • Shinelife
  • Adorefem
  • LG Chem
  • Adorshea
  • Biofield Pharma
  • Medibyte
  • Mestra Pharma
  • D Pharma
  • Abbott
  • Zydus
  • Takeda Pharmaceutical Company Limited
  • Merck KGaA
  • Ferring B.V.

Sources

Primary Research Interviews

• IVF Clinics and Hospitals
• IVF Drug Manufacturers
• Fertility Specialists and Gynecologists
• Nutraceutical Companies
• Food Supplement Manufacturers
• Healthcare Providers and Distributors
• End-Consumers (Patients, Couples undergoing IVF)

Databases

• Bloomberg Terminal
• Thomson Reuters Eikon
• IMS Health
• Others

Magazines

• IVF & Fertility News
• Fertility and Sterility Journal
• Nutraceuticals World
• Functional Foods & Nutraceuticals
• Pharmaceutical Technology Magazine
• Others

Journals

• Journal of Assisted Reproduction and Genetics
• Human Reproduction Journal
• International Journal of Fertility and Sterility
• Journal of Nutritional Science
• Clinical Nutrition Journal
• Others

Newspapers

• The National (UAE)
• Khaleej Times
• Gulf News
• The New York Times (International)
• The Financial Times
• Reuters
• Bloomberg News
• Others

Associations

• Emirates Fertility Society (EFS)
• Middle East Fertility Society (MEFS)
• World Health Organization (WHO) – Fertility & Reproductive Health
• International Federation of Fertility Societies (IFFS)
• International Food Information Council (IFIC)
• UAE Food and Drug Regulatory Authority (UAE FDA)
• Others

Public Domain Sources

• UAE Ministry of Health and Prevention
• World Health Organization (WHO)
• International Federation of Fertility Societies (IFFS)
• UAE National Center for Statistics and Information (NCSI)
• World Bank Open Data
• National Institute of Health (NIH) – Fertility and Reproductive Health Division
• Others

Proprietary Elements

• CMI Data Analytics Tool
• Proprietary CMI Existing Repository of Information for the Last 8 Years